Roche's Drug Monitoring Tests Kit Lands CE Mark Certification

MT Newswires · 3d ago
01:32 AM EST, 12/11/2025 (MT Newswires) -- Roche (ROG.SW) secured CE mark certification for its mass spectrometry reagent pack for therapeutic drug monitoring for immunosuppressants and antibiotics. The Swiss drug maker said Thursday that its cobas Mass Spec solution Ionify reagent portfolio also includes tests for the monitoring of steroid hormones and vitamin D metabolites. The test kit, which enables laboratories to transition to an automated system, is available in selected markets that accept the CE mark, and in other markets like the UK, Canada, and Japan.